
<div id="jpedal" style="overflow: hidden; position: relative; width: 909px; height: 1212px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_5{left:69px;top:86px;word-spacing:5.1px;}
#t2_5{left:69px;top:101px;word-spacing:7.1px;}
#t3_5{left:69px;top:116px;word-spacing:4.2px;}
#t4_5{left:69px;top:132px;word-spacing:2.2px;}
#t5_5{left:69px;top:147px;word-spacing:18.6px;}
#t6_5{left:69px;top:162px;}
#t7_5{left:69px;top:217px;word-spacing:4.6px;}
#t8_5{left:69px;top:237px;word-spacing:6.7px;}
#t9_5{left:69px;top:250px;word-spacing:3.4px;}
#ta_5{left:69px;top:264px;word-spacing:1.7px;}
#tb_5{left:69px;top:278px;word-spacing:10.1px;}
#tc_5{left:69px;top:291px;word-spacing:3.6px;}
#td_5{left:69px;top:343px;}
#te_5{left:75px;top:363px;word-spacing:7.1px;}
#tf_5{left:426px;top:363px;letter-spacing:0.1px;word-spacing:6.5px;}
#tg_5{left:85px;top:377px;word-spacing:3.7px;}
#th_5{left:345px;top:377px;word-spacing:3.6px;}
#ti_5{left:85px;top:390px;}
#tj_5{left:113px;top:390px;}
#tk_5{left:125px;top:390px;letter-spacing:0.1px;word-spacing:3.5px;}
#tl_5{left:75px;top:404px;word-spacing:1.8px;}
#tm_5{left:75px;top:418px;word-spacing:9.4px;}
#tn_5{left:250px;top:418px;word-spacing:8.9px;}
#to_5{left:85px;top:432px;word-spacing:4px;}
#tp_5{left:172px;top:432px;word-spacing:3.8px;}
#tq_5{left:75px;top:445px;word-spacing:5px;}
#tr_5{left:85px;top:459px;word-spacing:3.9px;}
#ts_5{left:296px;top:459px;word-spacing:3.7px;}
#tt_5{left:335px;top:459px;}
#tu_5{left:362px;top:459px;}
#tv_5{left:374px;top:459px;word-spacing:3.8px;}
#tw_5{left:75px;top:473px;word-spacing:2.6px;}
#tx_5{left:85px;top:486px;word-spacing:4.1px;}
#ty_5{left:192px;top:486px;word-spacing:3.4px;}
#tz_5{left:232px;top:486px;}
#t10_5{left:259px;top:486px;}
#t11_5{left:271px;top:486px;letter-spacing:0.1px;word-spacing:3.5px;}
#t12_5{left:75px;top:500px;word-spacing:6.8px;}
#t13_5{left:85px;top:514px;word-spacing:3.8px;}
#t14_5{left:230px;top:514px;word-spacing:3.7px;}
#t15_5{left:269px;top:514px;}
#t16_5{left:297px;top:514px;}
#t17_5{left:309px;top:514px;letter-spacing:0.1px;word-spacing:3.5px;}
#t18_5{left:75px;top:527px;word-spacing:4px;}
#t19_5{left:85px;top:541px;word-spacing:-0.1px;}
#t1a_5{left:85px;top:555px;word-spacing:3.7px;}
#t1b_5{left:159px;top:555px;word-spacing:4px;}
#t1c_5{left:210px;top:555px;}
#t1d_5{left:237px;top:555px;}
#t1e_5{left:243px;top:555px;word-spacing:3.5px;}
#t1f_5{left:75px;top:568px;word-spacing:4.7px;}
#t1g_5{left:85px;top:582px;word-spacing:5.5px;}
#t1h_5{left:85px;top:596px;word-spacing:3.9px;}
#t1i_5{left:285px;top:596px;word-spacing:4.1px;}
#t1j_5{left:424px;top:596px;}
#t1k_5{left:85px;top:610px;}
#t1l_5{left:103px;top:610px;word-spacing:3.5px;}
#t1m_5{left:75px;top:623px;word-spacing:16.6px;}
#t1n_5{left:85px;top:637px;word-spacing:3.7px;}
#t1o_5{left:225px;top:637px;word-spacing:3.7px;}
#t1p_5{left:253px;top:637px;}
#t1q_5{left:281px;top:637px;}
#t1r_5{left:298px;top:637px;word-spacing:3.5px;}
#t1s_5{left:69px;top:651px;word-spacing:8.2px;}
#t1t_5{left:85px;top:664px;word-spacing:3.8px;}
#t1u_5{left:315px;top:664px;word-spacing:3.4px;}
#t1v_5{left:344px;top:664px;}
#t1w_5{left:371px;top:664px;}
#t1x_5{left:389px;top:664px;word-spacing:3.8px;}
#t1y_5{left:69px;top:678px;word-spacing:2.8px;}
#t1z_5{left:366px;top:678px;letter-spacing:0.1px;word-spacing:2px;}
#t20_5{left:391px;top:678px;letter-spacing:0.1px;}
#t21_5{left:85px;top:692px;letter-spacing:-0.7px;word-spacing:1.4px;}
#t22_5{left:318px;top:692px;letter-spacing:3.3px;}
#t23_5{left:363px;top:692px;letter-spacing:-0.8px;}
#t24_5{left:389px;top:692px;}
#t25_5{left:394px;top:692px;letter-spacing:-0.6px;word-spacing:0.7px;}
#t26_5{left:69px;top:705px;word-spacing:4.8px;}
#t27_5{left:85px;top:719px;word-spacing:9.8px;}
#t28_5{left:85px;top:733px;word-spacing:4px;}
#t29_5{left:277px;top:733px;word-spacing:3.6px;}
#t2a_5{left:312px;top:733px;}
#t2b_5{left:339px;top:733px;}
#t2c_5{left:357px;top:733px;letter-spacing:2.9px;}
#t2d_5{left:390px;top:733px;}
#t2e_5{left:69px;top:747px;word-spacing:1.4px;}
#t2f_5{left:85px;top:760px;word-spacing:3.8px;}
#t2g_5{left:252px;top:760px;}
#t2h_5{left:285px;top:760px;}
#t2i_5{left:313px;top:760px;}
#t2j_5{left:330px;top:760px;word-spacing:3.5px;}
#t2k_5{left:69px;top:774px;word-spacing:5.7px;}
#t2l_5{left:85px;top:788px;word-spacing:0.1px;}
#t2m_5{left:369px;top:788px;word-spacing:-0.2px;}
#t2n_5{left:402px;top:788px;}
#t2o_5{left:428px;top:788px;}
#t2p_5{left:446px;top:788px;}
#t2q_5{left:85px;top:801px;letter-spacing:0.1px;}
#t2r_5{left:69px;top:815px;word-spacing:6.2px;}
#t2s_5{left:85px;top:829px;word-spacing:1px;}
#t2t_5{left:85px;top:842px;}
#t2u_5{left:127px;top:842px;word-spacing:3.8px;}
#t2v_5{left:256px;top:842px;}
#t2w_5{left:284px;top:842px;}
#t2x_5{left:290px;top:842px;letter-spacing:0.1px;word-spacing:3.5px;}
#t2y_5{left:69px;top:856px;word-spacing:15.8px;}
#t2z_5{left:85px;top:870px;word-spacing:6px;}
#t30_5{left:371px;top:870px;word-spacing:5.8px;}
#t31_5{left:400px;top:870px;}
#t32_5{left:428px;top:870px;}
#t33_5{left:446px;top:870px;}
#t34_5{left:85px;top:884px;letter-spacing:0.1px;}
#t35_5{left:69px;top:897px;word-spacing:11.8px;}
#t36_5{left:85px;top:911px;word-spacing:6.7px;}
#t37_5{left:417px;top:911px;word-spacing:6.4px;}
#t38_5{left:85px;top:925px;}
#t39_5{left:113px;top:925px;}
#t3a_5{left:131px;top:925px;letter-spacing:0.1px;word-spacing:3.5px;}
#t3b_5{left:69px;top:938px;word-spacing:8.6px;}
#t3c_5{left:85px;top:952px;word-spacing:3.6px;}
#t3d_5{left:298px;top:952px;letter-spacing:0.1px;word-spacing:3.6px;}
#t3e_5{left:345px;top:952px;}
#t3f_5{left:372px;top:952px;}
#t3g_5{left:378px;top:952px;word-spacing:3.5px;}
#t3h_5{left:69px;top:966px;word-spacing:5px;}
#t3i_5{left:476px;top:89px;word-spacing:7.1px;}
#t3j_5{left:801px;top:89px;word-spacing:6.5px;}
#t3k_5{left:828px;top:89px;}
#t3l_5{left:492px;top:103px;word-spacing:17px;}
#t3m_5{left:492px;top:116px;}
#t3n_5{left:525px;top:116px;}
#t3o_5{left:553px;top:116px;}
#t3p_5{left:564px;top:116px;letter-spacing:0.1px;word-spacing:3.5px;}
#t3q_5{left:476px;top:130px;word-spacing:12.7px;}
#t3r_5{left:492px;top:144px;word-spacing:3.6px;}
#t3s_5{left:648px;top:144px;word-spacing:3.4px;}
#t3t_5{left:677px;top:144px;}
#t3u_5{left:704px;top:144px;}
#t3v_5{left:722px;top:144px;letter-spacing:0.1px;word-spacing:3.8px;}
#t3w_5{left:476px;top:158px;word-spacing:3.1px;}
#t3x_5{left:492px;top:171px;word-spacing:3.4px;}
#t3y_5{left:651px;top:171px;word-spacing:3.8px;}
#t3z_5{left:776px;top:171px;}
#t40_5{left:803px;top:171px;}
#t41_5{left:815px;top:171px;letter-spacing:0.1px;word-spacing:3.5px;}
#t42_5{left:476px;top:185px;word-spacing:3.3px;}
#t43_5{left:492px;top:199px;word-spacing:3.8px;}
#t44_5{left:572px;top:199px;}
#t45_5{left:599px;top:199px;}
#t46_5{left:617px;top:199px;word-spacing:3.5px;}
#t47_5{left:476px;top:212px;word-spacing:5.8px;}
#t48_5{left:492px;top:226px;word-spacing:3.7px;}
#t49_5{left:730px;top:226px;word-spacing:3.7px;}
#t4a_5{left:759px;top:226px;}
#t4b_5{left:786px;top:226px;}
#t4c_5{left:804px;top:226px;word-spacing:3.8px;}
#t4d_5{left:476px;top:240px;word-spacing:7.8px;}
#t4e_5{left:799px;top:240px;word-spacing:7.6px;}
#t4f_5{left:826px;top:240px;}
#t4g_5{left:492px;top:253px;word-spacing:5.1px;}
#t4h_5{left:492px;top:267px;word-spacing:3.8px;}
#t4i_5{left:617px;top:267px;}
#t4j_5{left:644px;top:267px;}
#t4k_5{left:656px;top:267px;word-spacing:3.5px;}
#t4l_5{left:476px;top:281px;word-spacing:10.3px;}
#t4m_5{left:492px;top:294px;word-spacing:10.5px;}
#t4n_5{left:492px;top:308px;word-spacing:11.9px;}
#t4o_5{left:492px;top:322px;word-spacing:3.7px;}
#t4p_5{left:521px;top:322px;}
#t4q_5{left:548px;top:322px;}
#t4r_5{left:566px;top:322px;word-spacing:3.5px;}
#t4s_5{left:476px;top:336px;word-spacing:4.4px;}
#t4t_5{left:776px;top:336px;word-spacing:3.8px;}
#t4u_5{left:801px;top:336px;word-spacing:4.1px;}
#t4v_5{left:492px;top:349px;word-spacing:3.6px;}
#t4w_5{left:715px;top:349px;word-spacing:3.7px;}
#t4x_5{left:743px;top:349px;}
#t4y_5{left:771px;top:349px;}
#t4z_5{left:788px;top:349px;word-spacing:3.8px;}
#t50_5{left:476px;top:363px;word-spacing:10.4px;}
#t51_5{left:492px;top:377px;word-spacing:6.1px;}
#t52_5{left:492px;top:390px;word-spacing:4.2px;}
#t53_5{left:789px;top:390px;word-spacing:4.1px;}
#t54_5{left:831px;top:390px;}
#t55_5{left:492px;top:404px;}
#t56_5{left:504px;top:404px;letter-spacing:0.1px;word-spacing:3.5px;}
#t57_5{left:476px;top:418px;word-spacing:1.7px;}
#t58_5{left:492px;top:432px;word-spacing:1.9px;}
#t59_5{left:818px;top:432px;word-spacing:1.7px;}
#t5a_5{left:492px;top:445px;}
#t5b_5{left:519px;top:445px;}
#t5c_5{left:531px;top:445px;letter-spacing:0.1px;word-spacing:3.5px;}
#t5d_5{left:476px;top:459px;word-spacing:7.3px;}
#t5e_5{left:492px;top:473px;word-spacing:3.2px;}
#t5f_5{left:492px;top:486px;word-spacing:3.9px;}
#t5g_5{left:624px;top:486px;word-spacing:3.6px;}
#t5h_5{left:671px;top:486px;}
#t5i_5{left:699px;top:486px;}
#t5j_5{left:705px;top:486px;word-spacing:3.5px;}
#t5k_5{left:476px;top:500px;word-spacing:5.1px;}
#t5l_5{left:790px;top:500px;word-spacing:4.5px;}
#t5m_5{left:816px;top:500px;}
#t5n_5{left:492px;top:514px;word-spacing:3.7px;}
#t5o_5{left:492px;top:527px;word-spacing:3.7px;}
#t5p_5{left:668px;top:527px;}
#t5q_5{left:705px;top:527px;}
#t5r_5{left:733px;top:527px;}
#t5s_5{left:744px;top:527px;word-spacing:3.8px;}
#t5t_5{left:476px;top:541px;word-spacing:9.3px;}
#t5u_5{left:831px;top:541px;letter-spacing:0.1px;word-spacing:9px;}
#t5v_5{left:492px;top:555px;word-spacing:13.4px;}
#t5w_5{left:492px;top:568px;word-spacing:3.9px;}
#t5x_5{left:567px;top:568px;}
#t5y_5{left:594px;top:568px;}
#t5z_5{left:622px;top:568px;}
#t60_5{left:640px;top:568px;word-spacing:3.8px;}
#t61_5{left:476px;top:582px;word-spacing:0.7px;}
#t62_5{left:492px;top:596px;word-spacing:2.2px;}
#t63_5{left:492px;top:610px;letter-spacing:0.1px;}
#t64_5{left:555px;top:610px;word-spacing:3.8px;}
#t65_5{left:679px;top:610px;}
#t66_5{left:707px;top:610px;}
#t67_5{left:719px;top:610px;word-spacing:3.8px;}
#t68_5{left:476px;top:623px;word-spacing:6.6px;}
#t69_5{left:492px;top:637px;word-spacing:2.7px;}
#t6a_5{left:830px;top:637px;word-spacing:2.7px;}
#t6b_5{left:492px;top:651px;}
#t6c_5{left:519px;top:651px;}
#t6d_5{left:537px;top:651px;word-spacing:3.5px;}
#t6e_5{left:476px;top:664px;word-spacing:8px;}
#t6f_5{left:492px;top:678px;word-spacing:11.2px;}
#t6g_5{left:492px;top:692px;word-spacing:3.6px;}
#t6h_5{left:531px;top:692px;}
#t6i_5{left:558px;top:692px;}
#t6j_5{left:570px;top:692px;word-spacing:3.5px;}
#t6k_5{left:476px;top:705px;word-spacing:8.6px;}
#t6l_5{left:832px;top:705px;letter-spacing:0.1px;word-spacing:8.3px;}
#t6m_5{left:492px;top:719px;word-spacing:1.9px;}
#t6n_5{left:492px;top:733px;word-spacing:4.3px;}
#t6o_5{left:492px;top:747px;word-spacing:3.9px;}
#t6p_5{left:567px;top:747px;word-spacing:3.7px;}
#t6q_5{left:596px;top:747px;}
#t6r_5{left:623px;top:747px;}
#t6s_5{left:641px;top:747px;letter-spacing:0.1px;word-spacing:3.5px;}
#t6t_5{left:476px;top:760px;word-spacing:5.4px;}
#t6u_5{left:782px;top:760px;word-spacing:4.8px;}
#t6v_5{left:808px;top:760px;}
#t6w_5{left:492px;top:774px;word-spacing:-0.3px;}
#t6x_5{left:492px;top:788px;word-spacing:3.7px;}
#t6y_5{left:656px;top:788px;}
#t6z_5{left:688px;top:788px;}
#t70_5{left:715px;top:788px;}
#t71_5{left:733px;top:788px;word-spacing:3.5px;}
#t72_5{left:476px;top:801px;word-spacing:8.8px;}
#t73_5{left:769px;top:801px;word-spacing:8.6px;}
#t74_5{left:797px;top:801px;letter-spacing:0.1px;}
#t75_5{left:492px;top:815px;word-spacing:9.7px;}
#t76_5{left:492px;top:829px;}
#t77_5{left:560px;top:829px;word-spacing:3.8px;}
#t78_5{left:667px;top:829px;}
#t79_5{left:694px;top:829px;}
#t7a_5{left:706px;top:829px;word-spacing:3.5px;}
#t7b_5{left:476px;top:842px;word-spacing:7px;}
#t7c_5{left:492px;top:856px;word-spacing:3.5px;}
#t7d_5{left:492px;top:870px;word-spacing:1.1px;}
#t7e_5{left:492px;top:884px;word-spacing:3.7px;}
#t7f_5{left:640px;top:884px;word-spacing:3.6px;}
#t7g_5{left:748px;top:884px;}
#t7h_5{left:775px;top:884px;}
#t7i_5{left:787px;top:884px;word-spacing:3.8px;}
#t7j_5{left:476px;top:897px;word-spacing:3.7px;}
#t7k_5{left:492px;top:911px;word-spacing:4.1px;}
#t7l_5{left:492px;top:925px;word-spacing:3.7px;}
#t7m_5{left:629px;top:925px;word-spacing:3.6px;}
#t7n_5{left:677px;top:925px;}
#t7o_5{left:704px;top:925px;}
#t7p_5{left:710px;top:925px;word-spacing:3.5px;}
#t7q_5{left:476px;top:938px;word-spacing:1.2px;}
#t7r_5{left:731px;top:938px;word-spacing:0.3px;}
#t7s_5{left:755px;top:938px;word-spacing:0.5px;}
#t7t_5{left:492px;top:952px;word-spacing:1.1px;}
#t7u_5{left:806px;top:952px;word-spacing:1px;}
#t7v_5{left:492px;top:966px;word-spacing:3.8px;}
#t7w_5{left:563px;top:966px;}
#t7x_5{left:590px;top:966px;}
#t7y_5{left:602px;top:966px;word-spacing:3.5px;}
#t7z_5{left:82px;top:34px;word-spacing:3.9px;}
#t80_5{left:351px;top:49px;word-spacing:4px;}
#t81_5{left:426px;top:49px;word-spacing:4.2px;}
#t82_5{left:36px;top:69px;}
#t83_5{left:69px;top:1147px;word-spacing:2.8px;}
#t84_5{left:663px;top:1147px;}
#t85_5{left:676px;top:1147px;word-spacing:3.7px;}

.s8_5{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: JBCPDD-AdvOT7d2ebc015;
	color: rgb(35,31,32);
}

.s9_5{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: JBCOAH-AdvTA425;
	color: rgb(35,31,32);
}

.s6_5{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: JBCNFF-AdvOT46dcae815;
	color: rgb(35,31,32);
}

.s7_5{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: JBCNGH-AdvOT65f8a23b-I5;
	color: rgb(35,31,32);
}

.s5_5{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: JBCNGI-AdvOT3b30f6db-B5;
	color: rgb(35,31,32);
}

.s4_5{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: JBCNGH-AdvOT65f8a23b-I5;
	color: rgb(35,31,32);
}

.s3_5{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: JBCNFF-AdvOT46dcae815;
	color: rgb(35,31,32);
}

.s1_5{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: JBCNFF-AdvOT46dcae815;
	color: rgb(35,31,32);
}

.s2_5{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: JBCNGI-AdvOT3b30f6db-B5;
	color: rgb(35,31,32);
}

#form5_1{	border-style:none;	z-index:2;	position: absolute;	left:219px;	top:967px;	width:93px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts5" type="text/css" >

@font-face {
	font-family: JBCOAH-AdvTA425;
	src: url("5/fonts/JBCOAH-AdvTA42.woff") format("woff");
}

@font-face {
	font-family: JBCNFF-AdvOT46dcae815;
	src: url("5/fonts/JBCNFF-AdvOT46dcae81.woff") format("woff");
}

@font-face {
	font-family: JBCNGI-AdvOT3b30f6db-B5;
	src: url("5/fonts/JBCNGI-AdvOT3b30f6db-B.woff") format("woff");
}

@font-face {
	font-family: JBCNGH-AdvOT65f8a23b-I5;
	src: url("5/fonts/JBCNGH-AdvOT65f8a23b-I.woff") format("woff");
}

@font-face {
	font-family: JBCPDD-AdvOT7d2ebc015;
	src: url("5/fonts/JBCPDD-AdvOT7d2ebc01.woff") format("woff");
}

</style>
<div id="t1_5" class="t s1_5">despite a diagnosis of CaP. Furthermore, our data demonstrate a</div>
<div id="t2_5" class="t s1_5">lower rate of CaP recurrence in men on TRT than the published</div>
<div id="t3_5" class="t s1_5">recurrence rate for men with CaP not treated with TRT. However,</div>
<div id="t4_5" class="t s1_5">in the continued absence of randomized controlled trial data, TRT</div>
<div id="t5_5" class="t s1_5">in patients with CaP should be undertaken with appropriate</div>
<div id="t6_5" class="t s1_5">follow-up.</div>
<div id="t7_5" class="t s2_5">CONFLICT OF INTEREST</div>
<div id="t8_5" class="t s3_5">The authors declare the following potential conﬂict of interest. Mohit Khera: Slate</div>
<div id="t9_5" class="t s3_5">Pharmaceuticals—consultant; Auxilium Pharmaceuticals—speaker, research support;</div>
<div id="ta_5" class="t s3_5">Merck—consultant. Larry I Lipshultz: Auxilium Pharmaceuticals—consultant, speaker,</div>
<div id="tb_5" class="t s3_5">research support; Allergan Pharmaceuticals—research support. The other authors</div>
<div id="tc_5" class="t s3_5">declare no conﬂict of interest.</div>
<div id="td_5" class="t s2_5">REFERENCES</div>
<div id="te_5" class="t s3_5">1 Araujo AB, Esche GR, Kupelian V, O’Donnell AB, Travison TG, Williams RE</div>
<div id="tf_5" class="t s4_5">et al.</div>
<div id="tg_5" class="t s3_5">Prevalence of symptomatic androgen de±ciency in men.</div>
<div id="th_5" class="t s4_5">J Clin Endocrinol Metab</div>
<div id="ti_5" class="t s3_5">2007;</div>
<div id="tj_5" class="t s5_5">92</div>
<div id="tk_5" class="t s3_5">: 4241–4247.</div>
<div id="tl_5" class="t s3_5">2 Census UBot. Age and sex composition: 2010Census UBot: Washington, DC, 2011.</div>
<div id="tm_5" class="t s3_5">3 Society TE. The Endocrine Society.</div>
<div id="tn_5" class="t s4_5">Summary from the 2nd Annual Andropause</div>
<div id="to_5" class="t s4_5">Consensus Meeting</div>
<div id="tp_5" class="t s3_5">Chevy Chase, MD 2001.</div>
<div id="tq_5" class="t s3_5">4 Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone de±ciency: I.</div>
<div id="tr_5" class="t s3_5">Metabolic syndrome and erectile dysfunction.</div>
<div id="ts_5" class="t s4_5">J Androl</div>
<div id="tt_5" class="t s3_5">2009;</div>
<div id="tu_5" class="t s5_5">30</div>
<div id="tv_5" class="t s3_5">: 10–22.</div>
<div id="tw_5" class="t s3_5">5 Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone de±ciency: III.</div>
<div id="tx_5" class="t s3_5">Cardiovascular disease.</div>
<div id="ty_5" class="t s4_5">J Androl</div>
<div id="tz_5" class="t s3_5">2009;</div>
<div id="t10_5" class="t s5_5">30</div>
<div id="t11_5" class="t s3_5">: 477–494.</div>
<div id="t12_5" class="t s3_5">6 Traish AM, Saad F, Guay A. The dark side of testosterone de±ciency: II. Type 2</div>
<div id="t13_5" class="t s3_5">diabetes and insulin resistance.</div>
<div id="t14_5" class="t s4_5">J Androl</div>
<div id="t15_5" class="t s3_5">2009;</div>
<div id="t16_5" class="t s5_5">30</div>
<div id="t17_5" class="t s3_5">: 23–32.</div>
<div id="t18_5" class="t s3_5">7 Huggins C, Hudges CV. Studies on prostatic cancer. I. The effect of castration, of</div>
<div id="t19_5" class="t s3_5">estrogen and androgen injection on serum phosphatases in metastatic carcinoma</div>
<div id="t1a_5" class="t s3_5">of the prostate.</div>
<div id="t1b_5" class="t s4_5">Cancer Res</div>
<div id="t1c_5" class="t s3_5">1941;</div>
<div id="t1d_5" class="t s5_5">1</div>
<div id="t1e_5" class="t s3_5">: 293–297.</div>
<div id="t1f_5" class="t s3_5">8 Arnold JT, Le H, McFann KK, Blackman MR. Comparative effects of DHEA vs tes-</div>
<div id="t1g_5" class="t s3_5">tosterone, dihydrotestosterone, and estradiol on proliferation and gene expres-</div>
<div id="t1h_5" class="t s3_5">sion in human LNCaP prostate cancer cells.</div>
<div id="t1i_5" class="t s4_5">Am J Physiol Endocrinol Metab</div>
<div id="t1j_5" class="t s3_5">2005;</div>
<div id="t1k_5" class="t s5_5">288</div>
<div id="t1l_5" class="t s3_5">: E573–E584.</div>
<div id="t1m_5" class="t s3_5">9 Agarwal PK, Oefelein MG. Testosterone replacement therapy after primary</div>
<div id="t1n_5" class="t s3_5">treatment for prostate cancer.</div>
<div id="t1o_5" class="t s4_5">J Urol</div>
<div id="t1p_5" class="t s3_5">2005;</div>
<div id="t1q_5" class="t s5_5">173</div>
<div id="t1r_5" class="t s3_5">: 533–536.</div>
<div id="t1s_5" class="t s3_5">10 Kaufman JM, Graydon RJ. Androgen replacement after curative radical prosta-</div>
<div id="t1t_5" class="t s3_5">tectomy for prostate cancer in hypogonadal men.</div>
<div id="t1u_5" class="t s4_5">J Urol</div>
<div id="t1v_5" class="t s3_5">2004;</div>
<div id="t1w_5" class="t s5_5">172</div>
<div id="t1x_5" class="t s3_5">: 920–922.</div>
<div id="t1y_5" class="t s3_5">11 Khera M, Grober ED, Najari B, Colen JS, Mohamed O, Lamb DJ</div>
<div id="t1z_5" class="t s4_5">et al.</div>
<div id="t20_5" class="t s3_5">Testosterone</div>
<div id="t21_5" class="t s3_5">replacement therapy following radical prostatectomy.</div>
<div id="t22_5" class="t s4_5">JSexMed</div>
<div id="t23_5" class="t s3_5">2009;</div>
<div id="t24_5" class="t s5_5">6</div>
<div id="t25_5" class="t s3_5">: 1165–1170.</div>
<div id="t26_5" class="t s3_5">12 Morales A, Black AM, Emerson LE. Testosterone administration to men with tes-</div>
<div id="t27_5" class="t s3_5">tosterone de±ciency syndrome after external beam radiotherapy for localized</div>
<div id="t28_5" class="t s3_5">prostate cancer: preliminary observations.</div>
<div id="t29_5" class="t s4_5">BJU Int</div>
<div id="t2a_5" class="t s3_5">2009;</div>
<div id="t2b_5" class="t s5_5">103</div>
<div id="t2c_5" class="t s3_5">:62–64</div>
<div id="t2d_5" class="t s3_5">.</div>
<div id="t2e_5" class="t s3_5">13 Sarosdy MF. Testosterone replacement for hypogonadism after treatment of early</div>
<div id="t2f_5" class="t s3_5">prostate cancer with brachytherapy.</div>
<div id="t2g_5" class="t s4_5">Cancer</div>
<div id="t2h_5" class="t s3_5">2007;</div>
<div id="t2i_5" class="t s5_5">109</div>
<div id="t2j_5" class="t s3_5">: 536–541.</div>
<div id="t2k_5" class="t s3_5">14 Morales A. Effect of testosterone administration to men with prostate cancer is</div>
<div id="t2l_5" class="t s3_5">unpredictable: a word of caution and suggestions for a registry.</div>
<div id="t2m_5" class="t s4_5">BJU Int</div>
<div id="t2n_5" class="t s3_5">2011;</div>
<div id="t2o_5" class="t s5_5">107</div>
<div id="t2p_5" class="t s3_5">:</div>
<div id="t2q_5" class="t s3_5">1369–1373.</div>
<div id="t2r_5" class="t s3_5">15 Ferreira U, Leitao VA, Denardi F, Matheus WE, Stopiglia RM, Netto Jr. NR. Inter-</div>
<div id="t2s_5" class="t s3_5">mittent androgen replacement for intense hypogonadism symptoms in castrated</div>
<div id="t2t_5" class="t s3_5">patients.</div>
<div id="t2u_5" class="t s4_5">Prostate Cancer Prostatic Dis</div>
<div id="t2v_5" class="t s3_5">2006;</div>
<div id="t2w_5" class="t s5_5">9</div>
<div id="t2x_5" class="t s3_5">: 39–41.</div>
<div id="t2y_5" class="t s3_5">16 Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila Jr. D, Khera M.</div>
<div id="t2z_5" class="t s3_5">Testosterone therapy in men with untreated prostate cancer.</div>
<div id="t30_5" class="t s4_5">J Urol</div>
<div id="t31_5" class="t s3_5">2011;</div>
<div id="t32_5" class="t s5_5">185</div>
<div id="t33_5" class="t s3_5">:</div>
<div id="t34_5" class="t s3_5">1256–1260.</div>
<div id="t35_5" class="t s3_5">17 Leibowitz RL, Dorff TB, Tucker S, Symanowski J, Vogelzang NJ. Testosterone</div>
<div id="t36_5" class="t s3_5">replacement in prostate cancer survivors with hypogonadal symptoms.</div>
<div id="t37_5" class="t s4_5">BJU Int</div>
<div id="t38_5" class="t s3_5">2010;</div>
<div id="t39_5" class="t s5_5">105</div>
<div id="t3a_5" class="t s3_5">: 1397–1401.</div>
<div id="t3b_5" class="t s3_5">18 Jannini EA, Gravina GL, Morgentaler A, Morales A, Incrocci L, Hellstrom WJ. Is</div>
<div id="t3c_5" class="t s3_5">testosterone a friend or a foe of the prostate?</div>
<div id="t3d_5" class="t s4_5">J Sex Med</div>
<div id="t3e_5" class="t s3_5">2011;</div>
<div id="t3f_5" class="t s5_5">8</div>
<div id="t3g_5" class="t s3_5">: 946–955.</div>
<div id="t3h_5" class="t s3_5">19 NCCN. Prostate Cancer 2012. <a href="http://www.nccn.org." target="_blank">http://www.nccn.org.</a></div>
<div id="t3i_5" class="t s3_5">20 Daniell HW, Clark JC, Pereira SE, Niazi ZA, Ferguson DW, Dunn SR</div>
<div id="t3j_5" class="t s4_5">et al.</div>
<div id="t3k_5" class="t s3_5">Hypo-</div>
<div id="t3l_5" class="t s3_5">gonadism following prostate-bed radiation therapy for prostate carcinoma.</div>
<div id="t3m_5" class="t s4_5">Cancer</div>
<div id="t3n_5" class="t s3_5">2001;</div>
<div id="t3o_5" class="t s5_5">91</div>
<div id="t3p_5" class="t s3_5">: 1889–1895.</div>
<div id="t3q_5" class="t s3_5">21 Pickles T, Graham P. What happens to testosterone after prostate radiation</div>
<div id="t3r_5" class="t s3_5">monotherapy and does it matter?</div>
<div id="t3s_5" class="t s4_5">J Urol</div>
<div id="t3t_5" class="t s3_5">2002;</div>
<div id="t3u_5" class="t s5_5">167</div>
<div id="t3v_5" class="t s3_5">: 2448–2452.</div>
<div id="t3w_5" class="t s3_5">22 Zagars GK, Pollack A. Serum testosterone levels after external beam radiation for</div>
<div id="t3x_5" class="t s3_5">clinically localized prostate cancer.</div>
<div id="t3y_5" class="t s4_5">Int J Radiat Oncol Biol Phys</div>
<div id="t3z_5" class="t s3_5">1997;</div>
<div id="t40_5" class="t s5_5">39</div>
<div id="t41_5" class="t s3_5">: 85–89.</div>
<div id="t42_5" class="t s3_5">23 Kinsella TJ. Effects of radiation therapy and chemotherapy on testicular function.</div>
<div id="t43_5" class="t s4_5">Prog Clin Biol Res</div>
<div id="t44_5" class="t s3_5">1989;</div>
<div id="t45_5" class="t s5_5">302</div>
<div id="t46_5" class="t s3_5">: 157–171(discussion 172–157).</div>
<div id="t47_5" class="t s3_5">24 Grigsby PW, Perez CA. The effects of external beam radiotherapy on endocrine</div>
<div id="t48_5" class="t s3_5">function in patients with carcinoma of the prostate.</div>
<div id="t49_5" class="t s4_5">J Urol</div>
<div id="t4a_5" class="t s3_5">1986;</div>
<div id="t4b_5" class="t s5_5">135</div>
<div id="t4c_5" class="t s3_5">: 726–727.</div>
<div id="t4d_5" class="t s3_5">25 Taira AV, Merrick GS, Galbreath RW, Butler WM, Lief JH, Allen ZA</div>
<div id="t4e_5" class="t s4_5">et al.</div>
<div id="t4f_5" class="t s3_5">Serum</div>
<div id="t4g_5" class="t s3_5">testosterone kinetics after brachytherapy for clinically localized prostate cancer.</div>
<div id="t4h_5" class="t s4_5">Int J Radiat Oncol Biol Phys</div>
<div id="t4i_5" class="t s3_5">2012;</div>
<div id="t4j_5" class="t s5_5">82</div>
<div id="t4k_5" class="t s3_5">: e33–e38.</div>
<div id="t4l_5" class="t s3_5">26 Tomic R, Bergman B, Damber JE, Littbrand B, Lofroth PO. Effects of external</div>
<div id="t4m_5" class="t s3_5">radiation therapy for cancer of the prostate on the serum concentrations of</div>
<div id="t4n_5" class="t s3_5">testosterone, follicle-stimulating hormone, luteinizing hormone and prolactin.</div>
<div id="t4o_5" class="t s4_5">J Urol</div>
<div id="t4p_5" class="t s3_5">1983;</div>
<div id="t4q_5" class="t s5_5">130</div>
<div id="t4r_5" class="t s3_5">: 287–289.</div>
<div id="t4s_5" class="t s3_5">27 Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI</div>
<div id="t4t_5" class="t s4_5">et al.</div>
<div id="t4u_5" class="t s3_5">Inﬂuence of</div>
<div id="t4v_5" class="t s3_5">radical prostatectomy on serum hormone levels.</div>
<div id="t4w_5" class="t s4_5">J Urol</div>
<div id="t4x_5" class="t s3_5">1998;</div>
<div id="t4y_5" class="t s5_5">160</div>
<div id="t4z_5" class="t s3_5">: 449–453.</div>
<div id="t50_5" class="t s3_5">28 Lukkarinen O. Total and SHBG-bound testosterone and 5 alpha-dihydrotesto-</div>
<div id="t51_5" class="t s3_5">sterone serum concentrations in normal elderly men and patients with benign</div>
<div id="t52_5" class="t s3_5">prostatic hypertrophy before and after removal of the adenoma.</div>
<div id="t53_5" class="t s4_5">Br J Urol</div>
<div id="t54_5" class="t s3_5">1980;</div>
<div id="t55_5" class="t s5_5">52</div>
<div id="t56_5" class="t s3_5">: 377–380.</div>
<div id="t57_5" class="t s3_5">29 Ghanadian R, Puah CM, Williams G, Shah PJ, McWhinney N. Suppressive effects of</div>
<div id="t58_5" class="t s3_5">surgical stress on circulating androgens during and after prostatectomy.</div>
<div id="t59_5" class="t s4_5">Br J Urol</div>
<div id="t5a_5" class="t s3_5">1981;</div>
<div id="t5b_5" class="t s5_5">53</div>
<div id="t5c_5" class="t s3_5">: 147–149.</div>
<div id="t5d_5" class="t s3_5">30 McCullough AR, Khera M, Goldstein I, Hellstrom WJ, Morgentaler A, Levine LA.</div>
<div id="t5e_5" class="t s3_5">A Multi-institutional observational study of testosterone levels after testosterone</div>
<div id="t5f_5" class="t s3_5">pellet (Testopel(R)) insertion.</div>
<div id="t5g_5" class="t s4_5">J Sex Med</div>
<div id="t5h_5" class="t s3_5">2012;</div>
<div id="t5i_5" class="t s5_5">9</div>
<div id="t5j_5" class="t s3_5">: 594–601.</div>
<div id="t5k_5" class="t s3_5">31 Kattan MW, Potters L, Blasko JC, Beyer DC, Fearn P, Cavanagh W</div>
<div id="t5l_5" class="t s4_5">et al.</div>
<div id="t5m_5" class="t s3_5">Pretreat-</div>
<div id="t5n_5" class="t s3_5">ment nomogram for predicting freedom from recurrence after permanent pros-</div>
<div id="t5o_5" class="t s3_5">tate brachytherapy in prostate cancer.</div>
<div id="t5p_5" class="t s4_5">Urology</div>
<div id="t5q_5" class="t s3_5">2001;</div>
<div id="t5r_5" class="t s5_5">58</div>
<div id="t5s_5" class="t s3_5">: 393–399.</div>
<div id="t5t_5" class="t s3_5">32 Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA</div>
<div id="t5u_5" class="t s4_5">et al.</div>
<div id="t5v_5" class="t s3_5">Radiation therapy for clinically ocalized prostate cancer: a multi-institutional</div>
<div id="t5w_5" class="t s3_5">pooled analysis.</div>
<div id="t5x_5" class="t s4_5">JAMA</div>
<div id="t5y_5" class="t s3_5">1999;</div>
<div id="t5z_5" class="t s5_5">281</div>
<div id="t60_5" class="t s3_5">: 1598–1604.</div>
<div id="t61_5" class="t s3_5">33 Pollack A, Hanlon AL, Movsas B, Hanks GE, Uzzo R, Horwitz EM. Biochemical failure</div>
<div id="t62_5" class="t s3_5">as a determinant of distant metastasis and death in prostate cancer treated with</div>
<div id="t63_5" class="t s3_5">radiotherapy.</div>
<div id="t64_5" class="t s4_5">Int J Radiat Oncol Biol Phys</div>
<div id="t65_5" class="t s3_5">2003;</div>
<div id="t66_5" class="t s5_5">57</div>
<div id="t67_5" class="t s3_5">: 19–23.</div>
<div id="t68_5" class="t s3_5">34 Holzman M, Carlton Jr. CE , Scardino PT. The frequency and morbidity of local</div>
<div id="t69_5" class="t s3_5">tumor recurrence after de±nitive radiotherapy for stage C prostate cancer.</div>
<div id="t6a_5" class="t s4_5">J Urol</div>
<div id="t6b_5" class="t s3_5">1991;</div>
<div id="t6c_5" class="t s5_5">146</div>
<div id="t6d_5" class="t s3_5">: 1578–1582.</div>
<div id="t6e_5" class="t s3_5">35 Morgentaler A, Traish AM. Shifting the paradigm of testosterone and prostate</div>
<div id="t6f_5" class="t s3_5">cancer: the saturation model and the limits of androgen-dependent growth.</div>
<div id="t6g_5" class="t s4_5">Eur Urol</div>
<div id="t6h_5" class="t s3_5">2009;</div>
<div id="t6i_5" class="t s5_5">55</div>
<div id="t6j_5" class="t s3_5">: 310–320.</div>
<div id="t6k_5" class="t s3_5">36 Horwitz EM, Thames HD, Kuban DA, Levy LB, Kupelian PA, Martinez AA</div>
<div id="t6l_5" class="t s4_5">et al.</div>
<div id="t6m_5" class="t s3_5">De±nitions of biochemical failure that best predict clinical failure in patients with</div>
<div id="t6n_5" class="t s3_5">prostate cancer treated with external beam radiation alone: a multi-institutional</div>
<div id="t6o_5" class="t s3_5">pooled analysis.</div>
<div id="t6p_5" class="t s4_5">J Urol</div>
<div id="t6q_5" class="t s3_5">2005;</div>
<div id="t6r_5" class="t s5_5">173</div>
<div id="t6s_5" class="t s3_5">: 797–802.</div>
<div id="t6t_5" class="t s3_5">37 Warde P, Mason M, Ding K, Kirkbride P, Brundage M, Cowan R</div>
<div id="t6u_5" class="t s4_5">et al.</div>
<div id="t6v_5" class="t s3_5">Combined</div>
<div id="t6w_5" class="t s3_5">androgen deprivation therapy and radiation therapy for locally advanced prostate</div>
<div id="t6x_5" class="t s3_5">cancer: a randomised, phase 3 trial.</div>
<div id="t6y_5" class="t s4_5">Lancet</div>
<div id="t6z_5" class="t s3_5">2011;</div>
<div id="t70_5" class="t s5_5">378</div>
<div id="t71_5" class="t s3_5">: 2104–2111.</div>
<div id="t72_5" class="t s3_5">38 Bachman E, Feng R, Travison T, Li M, Olbina G, Ostland V</div>
<div id="t73_5" class="t s4_5">et al.</div>
<div id="t74_5" class="t s3_5">Testosterone</div>
<div id="t75_5" class="t s3_5">suppresses hepcidin in men: a potential mechanism for testosterone-induced</div>
<div id="t76_5" class="t s3_5">erythrocytosis.</div>
<div id="t77_5" class="t s4_5">J Clin Endocrinol Metab</div>
<div id="t78_5" class="t s3_5">2010;</div>
<div id="t79_5" class="t s5_5">95</div>
<div id="t7a_5" class="t s3_5">: 4743–4747.</div>
<div id="t7b_5" class="t s3_5">39 Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE, Mazer NA. Pharmaco-</div>
<div id="t7c_5" class="t s3_5">kinetics ef±cacy, and safety of a permeation-enhanced testosterone transdermal</div>
<div id="t7d_5" class="t s3_5">system in comparison with bi-weekly injections of testosterone enanthate for the</div>
<div id="t7e_5" class="t s3_5">treatment of hypogonadal men.</div>
<div id="t7f_5" class="t s4_5">J Clin Endocrinol Metab</div>
<div id="t7g_5" class="t s3_5">1999;</div>
<div id="t7h_5" class="t s5_5">84</div>
<div id="t7i_5" class="t s3_5">: 3469–3478.</div>
<div id="t7j_5" class="t s3_5">40 Kaminetsky JC, Moclair B, Hemani M, Sand M. A phase IV prospective evaluation</div>
<div id="t7k_5" class="t s3_5">of the safety and ef±cacy of extended release testosterone pellets for the treat-</div>
<div id="t7l_5" class="t s3_5">ment of male hypogonadism.</div>
<div id="t7m_5" class="t s4_5">J Sex Med</div>
<div id="t7n_5" class="t s3_5">2011;</div>
<div id="t7o_5" class="t s5_5">8</div>
<div id="t7p_5" class="t s3_5">: 1186–1196.</div>
<div id="t7q_5" class="t s3_5">41 Vicini FA, Shah C, Kestin L, Ghilezan M, Krauss D, Ye H</div>
<div id="t7r_5" class="t s4_5">et al.</div>
<div id="t7s_5" class="t s3_5">Identifying differences</div>
<div id="t7t_5" class="t s3_5">between biochemical failure and cure: incidence rates and predictors.</div>
<div id="t7u_5" class="t s4_5">Int J Radiat</div>
<div id="t7v_5" class="t s4_5">Oncol Biol Phys</div>
<div id="t7w_5" class="t s3_5">2011;</div>
<div id="t7x_5" class="t s5_5">81</div>
<div id="t7y_5" class="t s3_5">: e369–e375.</div>
<div id="t7z_5" class="t s6_5">Testosterone replacement after radiation treatment for prostate cancer</div>
<div id="t80_5" class="t s6_5">AW Pastuszak</div>
<div id="t81_5" class="t s7_5">et al</div>
<div id="t82_5" class="t s8_5">28</div>
<div id="t83_5" class="t s6_5">International Journal of Impotence Research (2013), 24 – 28</div>
<div id="t84_5" class="t s9_5">&amp;</div>
<div id="t85_5" class="t s6_5">2013 Macmillan Publishers Limited</div>

<form>
<input type="button"  tabindex="1"  id="form5_1" name="39 0 R"  pdfFieldName="39 0 R" onclick="window.open('http://www.nccn.org','_blank');" style="cursor:pointer;" title="http://www.nccn.org" />

</form>
<div id="pg5Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg5"><object width="909" height="1212" data="5/5.svg" type="image/svg+xml" id="pdf5" style="width:909px; height:1212px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 294;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_5");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
